NCT04244006View on ClinicalTrials.gov

A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 23, 2020

Primary Completion Date

June 1, 2024

Study Completion Date

June 1, 2024

Conditions
Netherton Syndrome
Interventions
DRUG

Dupilumab Prefilled Syringe

administration of dupilumab corresponding to dupilumab arm

OTHER

Placebo Prefilled Syringe

administration of placebo corresponding to placebo arm

Trial Locations (2)

75015

NOT_YET_RECRUITING

Dermatologie Necker, Paris

Unknown

RECRUITING

Dermatology, Toulouse

Sponsors

Collaborators (1)

MedSharing
All Listed Sponsors
collaborator

MedSharing

UNKNOWN

lead

University Hospital, Toulouse

OTHER

NCT04244006 - A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome | Biotech Hunter | Biotech Hunter